Pancreatic Cancer Research

ResearcherUniversity of California, San FranciscoNo recent work listed

Douglas Hanahan

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-0883-5251; OpenAlex author ID A5007537368. Sources: funder_awards.

Their work

Papers
3
Trials
0
Grants
1
Labs led
0
Collaborators
13
Papers, trials and grants by year

2007: 1 grant · 2008: none · 2009: none · 2010: none · 2011: 1 paper · 2012: none · 2013: 1 paper · 2014: none · 2015: none · 2016: 1 paper

Papers 3

  1. Procathepsin E is highly abundant but minimally active in pancreatic ductal adenocarcinoma tumors. Co-author DOI 10.1515/hsz-2016-0138↗
  2. Targeting cathepsin E in pancreatic cancer by a small molecule allows in vivo detection. Co-author DOI 10.1593/neo.13276↗
  3. Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy. Co-author DOI 10.1038/nm.2344↗

Grants 1

  1. Assessing Mechanisms and Therapeutic Potential of an Aspartyle Protease in Pancreatic Cancer AWARD pancan:2007-douglas-hanahan-phd-assessing-mechanisms-and-therapeutic-pot

Closest collaborators

The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Anthony John O’Donoghue · 1 shared paper, 2016 · strength 0.07
  2. Charles S. Craik · 1 shared paper, 2016 · strength 0.07
  3. Edmund J. Keliher · 1 shared paper, 2013 · strength 0.03
  4. Ronald Anthony Depinho · 1 shared paper, 2013 · strength 0.03
  5. Ralph Weissleder · 1 shared paper, 2013 · strength 0.03
  6. Nabeel M. Bardeesy · 1 shared paper, 2013 · strength 0.03
  7. Andrew H. Ko · 1 shared paper, 2011 · strength 0.02
  8. Anguraj Sadanandam · 1 shared paper, 2011 · strength 0.02
  9. Joe W. Gray · 1 shared paper, 2011 · strength 0.02
  10. Paul T. Spellman · 1 shared paper, 2011 · strength 0.02
  11. Grace Kim · 1 shared paper, 2011 · strength 0.02
  12. Eric Andrew Collisson · 1 shared paper, 2011 · strength 0.02
  13. Margaret A. Tempero · 1 shared paper, 2011 · strength 0.02

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.